Society of Endometriosis and Uterine Disorders forum: adenomyosis today, Paris, France, December 12, 2023

article OA: gold CC0
AI-generated summary by claude@2026-06, 2026-06-06

An expert symposium convened to discuss current understanding and future research directions for adenomyosis, highlighting recent advances and persistent challenges in the field.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Recognizing the limited information, vague diagnostic criterion, and difficult clinical challenges posed by adenomyosis, the Society of Endometriosis and Uterine Disorders organized an expert symposium to present the current understanding of adenomyosis, as well as important questions for future research. The purpose of the meeting was to bring together a diverse group of specialists to highlight both advances and future areas of growth over a wide range of topics related to adenomyosis. The presentations demonstrated both the novel insights and therapeutic progress over the past several decades, as well as the often frustrating challenges in moving adenomyosis research forward. This article summarizes the presentations provided by participants and, as such, does not serve as an exhaustive structured review on the topic of adenomyosis as a disease process.

My notes (saved in your browser only)

Condition tags

endometriosisadenomyosis

MeSH descriptors

Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (76)

Source provenance

europepmc
last seen: 2026-07-25T06:15:30.875455+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-07-25T06:12:39.725805+00:00
License: CC0 · commercial use OK